Skip to main content

Published locations for FDA approves risankizumab (Skyrizi) for Crohn’s disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves risankizumab (Skyrizi) for Crohn’s disease

User login

  • Reset your password
  • /content/fda-approves-risankizumab-skyrizi-crohns-disease
  • /clinicianreviews/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease
  • /familypracticenews/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease
  • /fedprac/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease
  • /gihepnews/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease
  • /internalmedicinenews/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns
  • /internalmedicine/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease
  • /familymedicine/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease
  • /emergencymedicine/article/255526/gastroenterology/fda-approves-risankizumab-skyrizi-crohns-disease